Opioid Task Force Recommendations, Colorado Consortium for Prescription Drug Abuse Prevention
Presented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
First Regular Session | 75th General Assembly
Colorado General AssemblyPresented to the Opioid and Other Substance Use Disorders Interim Study Committee at its September 2017 meeting.
Final Report to the Colorado General Assembly by the Oversight Committee on Mental Illness in the Criminal Justice System.
This issue brief outlines Colorado's efforts to address issues associated with persons with mental illness in the criminal justice system.
Colorado receives annual payments from tobacco manufacturers as part of the Tobacco Master Settlement Agreement. In April 2016, the state received $92.3 million. This memorandum presents the distribution of the 2016 payment and forecasts payments through 2019.
Presented to the Joint Health Committee on January 6, 2017.
Presented to the Joint Health Committee on January 6, 2017.
Presented to the Joint Health Committee.
Presented to the Joint Health Committee at its meeting on January 6, 2017.
Presented to the Joint Health Committee at its January 6, 2017, meeting.
Presented to the Joint Health Committee at its January 6, 2017, meeting.
Joint Presentation to the Senate Health & Human Services Committee, House Health, Insurance, & Environment Committee, and House Public Health Care & Human Services Committee on January 9, 2017.
The effective date for bills enacted without a safety clause is August 6, 2025, if the General Assembly adjourns sine die on May 7, 2025 (unless otherwise specified). Details